University of Alabama at Birmingham
Scores focused on the biochemical pathways associated with disease and pairing these scores with other risk assessments could improve predictive value, the data showed.
Clovis Oncology Begins Study of FAP-2286 Targeted Imaging Agent, Radionuclide Therapy
The Phase I/II LuMIERE study is enrolling patients with different types of tumors at the O'Neal Comprehensive Cancer Center in Alabama.
O'Neal Comprehensive Cancer Center, My Gene Counsel Partner for Digital Genetic Testing Support
The cancer center will use My Gene Counsel’s digital genetic counseling platform to better support patients and physicians and free up genetic counseling resources.
Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project
The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.